Iron Gate Global Advisors LLC lessened its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 25.8% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,723 shares of the company's stock after selling 6,165 shares during the quarter. Iron Gate Global Advisors LLC's holdings in HealthEquity were worth $1,566,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of HQY. Invesco Ltd. boosted its position in shares of HealthEquity by 50.6% in the first quarter. Invesco Ltd. now owns 2,446,198 shares of the company's stock valued at $216,171,000 after acquiring an additional 821,425 shares during the period. Nuveen LLC bought a new stake in shares of HealthEquity in the first quarter valued at about $53,076,000. Price T Rowe Associates Inc. MD lifted its position in HealthEquity by 995.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company's stock worth $56,500,000 after purchasing an additional 580,988 shares during the period. Westfield Capital Management Co. LP bought a new stake in HealthEquity during the first quarter worth about $49,787,000. Finally, Ameriprise Financial Inc. lifted its position in HealthEquity by 148.1% during the first quarter. Ameriprise Financial Inc. now owns 669,939 shares of the company's stock worth $59,203,000 after purchasing an additional 399,897 shares during the period. Institutional investors own 99.55% of the company's stock.
Wall Street Analyst Weigh In
HQY has been the subject of several recent analyst reports. JMP Securities upped their price objective on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research report on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, June 5th. JPMorgan Chase & Co. upped their price objective on shares of HealthEquity from $125.00 to $126.00 and gave the stock an "overweight" rating in a research report on Wednesday, September 3rd. Barrington Research reaffirmed an "outperform" rating and set a $125.00 price objective on shares of HealthEquity in a research report on Friday, August 29th. Finally, Wall Street Zen raised shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $119.77.
Get Our Latest Report on HQY
HealthEquity Stock Performance
HealthEquity stock opened at $91.51 on Thursday. The business has a 50 day moving average of $93.74 and a 200-day moving average of $94.72. HealthEquity, Inc. has a 1 year low of $74.07 and a 1 year high of $116.65. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. The company has a market capitalization of $7.88 billion, a P/E ratio of 55.46, a P/E/G ratio of 1.33 and a beta of 0.50.
Insider Activity
In other news, EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the transaction, the executive vice president owned 53,225 shares of the company's stock, valued at $5,414,579.25. This represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 1.50% of the stock is owned by corporate insiders.
About HealthEquity
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Further Reading
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
